PublizoomMerz Therapeutics Iberia S.L.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 2
- Shared contracts
- 2 (multi-supplier framework agreements)
- Period
- 2 October 2026 – 19 October 2026
Its main clients
Where and what
Supplies · 2
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 14 April 2028 re-tender around October 2027 |
26Far019 c)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL |
LABORATORIOS FARMACEUTICOS ROVI, S.A. LUNDBECK ESPAÑA, S.A.U. MENARINI STEMLINE ESPAÑA, S.L.U Merz Therapeutics Iberia S.L. PFIZER, S.L.U. ROCHE FARMA, S.A. TAKEDA FARMACÉUTICA ESPAÑA S.A. 1 bid received |
€808,514 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 19/10/2026 | 26Far019 c)suministro de medicamentos "exclusivos" (i) | CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL | €808,514 shared by 7 |
| 02/10/2026 | Suministro de medicamentos toxina botulínica (DOE) tipo A | Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | €290,141 shared by 3 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.